Terms ending in 2042
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,240,867 | Arginase Inhibitors and Methods of Use In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,144,855 | Methods for Producing Streptococcus Pneumoniae Capsular Polysaccharide Carrier Protein Conjugates from Lyospheres In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,227,536 | Novel Crystalline Forms of an Nrtti Compound In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,110,330 | Compositions of Programmed Death Receptor 1 (PD-1) Antibodies and Methods of Obtaining the Compositions Thereof In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,258,329 | Pyrimidone Derivatives as Selective Cytotoxic Agents Against HIV Infected Cells In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,246,008 | 4-Amino or 4-Alkoxy-SUBSTITUTED Aryl Sulfonamide Compounds with Selective Activity in Voltage-Gated Sodium Channels In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,247,031 | Cyclobutyl Pyrazolopyrimidine PDE9 Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,319,735 | Co-Formulations of ANTI-LAG3 Antibodies and ANTI-PD-1 Antibodies In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,365,706 | Macrocyclic Peptides as Potent Inhibitors of K-Ras G12D Mutant In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,958,864 | Tetracyclic Heterocycle Compounds Useful as HIV Integrase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 48 more term ends in 2042 · Pro | |||||
10 of 58 patents shown. Soonest term end first, then patent number.
Pro members see all 58.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.